Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Sprout Health vs Teleios Health

Sprout Health
Graded #6

Higher grade

vs+26.200000000000003
Teleios Health
Graded #327

Lower grade

The verdict

Sprout Health takes it — 86.4/100 to 60.2/100.

Sprout Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSprout Health +6
90
84
Dose & formulationSprout Health +18
82
64
Clinical oversightSprout Health +39
88
49
Labs & monitoringSprout Health +44
92
48
FulfillmentSprout Health +36
78
42
Contract termsSprout Health +29
84
55
Sprout Health · left barTeleios Health · right bar

The numbers

MetricSprout HealthTeleios Health
WeighScore86.4/10060.2/100
GradeBC
Scorecard rank#6#327
Semaglutide$149/mo$99/mo (starting dose, compounded)
Tirzepatide$199/mo$139/mo (starting dose, compounded)
CoverageNot disclosedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Sprout Health

Graded #6 · B

Strengths

  • LegitScript-certified with a listed address and contact line
  • Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
  • Low-friction intake — no labs and often no telehealth visit required

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved
  • No oral or sublingual route — injectable only
  • Thin transparency — no named medical director, and state availability is quiz-gated
  • "No labs, no visit" convenience also means lighter clinical oversight
Teleios Health

Graded #327 · C

Strengths

  • Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
  • Compounded tirzepatide from a competitive $139/mo floor
  • Markets physician (MD/DO) prescribing rather than an NP-only model
  • Clean meta-tag and SEO implementation

Where it loses points

  • Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
  • No named medical director, physician, or corporate entity disclosed
  • Year founded unknown — a newer floor-price entrant warranting extra scrutiny
  • No LegitScript, NABP, or SOC 2 trust signal found
  • Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard